Clinical Trials Logo
  1. Home
  2. Other
  3. NCT06460558

T1D Closed-loop and Physical Activity

Diabetes type1 Clinical Trial

Official title:
"Impact of an Automated Closed-loop Insulin Infusion System on Adherence to Physical Activity in Patients With Type 1 Diabetes "

Clinical Trial Summary

"Physical activity is recognized as beneficial for patients living with type 1 diabetes (T1DM), with a demonstrated effect not only on HbA1c control [1] but also on reducing the incidence of diabetes-related complications [2,3]. It is recommended that patients living with T1DM perform 150 minutes of accumulated physical activity per week, without exceeding two consecutive days without physical activity [4]. Indeed, one meta-analysis reported that moderately vigorous activity (≥4.5 METs) was beneficial compared with lower-intensity activity, while three other studies noted that only vigorous physical activity (≥6 METs) predicted lower all-cause mortality rates [5]. However, T1DM can represent a major obstacle to physical activity because of the occurrence of fairly frequent hypoglycemia, including after physical effort, the need for early resugaring but also the risk of hyperglycemia (rebound or with certain activities) [6]. The advent of automated insulin delivery systems has led to a significant improvement in time on target and a reduction in the frequency of hypoglycemia, including during physical activity in some studies [7-9]. The aim of this study is therefore to evaluate, in a cohort of patients with T1DM, whether the implementation of a closed-loop automated insulin delivery system increases physical activity in patients with T1DM. Based on the interpretation of the ONAPS-PAQ [10], the investigator hypothesize that the implementation of the closed-loop system enables an individual to reach the 3000 MET/min/week threshold (considered ""Active+"" from this threshold onwards).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06460558
Study type Observational
Source Centre Hospitalier Universitaire de Nice
Contact Nicolas CHEVALIER, MD
Phone 0492035519
Email chevalier.n@chu-nice.fr
Status Recruiting
Phase
Start date May 6, 2024
Completion date May 6, 2026
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05437913 - Protocol for Self-Compassion Intervention for Teens With Diabetes Type 1 and Their Caregivers N/A
Recruiting NCT03565770 - Assessment of Individual Follow-up by Coaching Program for Type 1 Diabetes Children N/A
Not yet recruiting NCT06437782 - Exploration of Health Literacy in Diabetes in Reunion Island and France
Not yet recruiting NCT05990933 - Role of Adrenaline in in the Inflammatory Response in Diabetes N/A
Recruiting NCT05669547 - Dual Hormone Closed Loop in Type 1 Diabetes N/A
Completed NCT03751007 - A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D) Phase 1/Phase 2
Recruiting NCT06190756 - Impact of Gravity on Cardiac Hemodynamics N/A
Completed NCT05069727 - Simple Initiation of Advanced Hybrid Closed Loop System N/A
Recruiting NCT05866536 - Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years Phase 2
Not yet recruiting NCT06405386 - Pilot of Pragmatic Delivery of Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes N/A
Not yet recruiting NCT06405373 - Pragmatic Delivery of Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes N/A
Completed NCT04635280 - Evaluation of Satisfaction Regarding Home Healthcare Provider (HHP) Management of Type 1 Diabetic Patients Using a Closed-loop Automatic Insulin Delivery System N/A
Completed NCT05168657 - Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth N/A
Active, not recruiting NCT05574062 - Evaluation of the MiniMed 780 System in Paediatric Subjects N/A
Recruiting NCT05180591 - Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes Phase 2
Recruiting NCT05176795 - Host-microbiota-environment Interactions
Completed NCT05284071 - Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation N/A
Completed NCT05933460 - Crocus Sativus Extract Impact in Metabolic Control of Patients With Diabetes Mellitus Type 1 N/A
Not yet recruiting NCT04772729 - Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes? Phase 4
Not yet recruiting NCT03170089 - Oral Health Awareness and Oral Hygiene in Insulin Dependent Diabetes Mellitus N/A